MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from notes
payable issuance-Notes...
$108,787K
Maturities and sales of
short-term investments
$17,956K
Loss on
extinguishment of debt
-$11,339K
Proceeds from notes
payable issuance-Two...
$33,250K
Proceeds from the sale of
common stock
$19,838K
Proceeds from sale of
series a convertible...
$7,862K
Proceeds from sale of
property and equipment
$29K
Inventory
-$2,940K
Stock-based compensation
expense
$2,852K
Other accrued
expenses
$2,511K
Accrued clinical and
manufacturing liabilities
$2,296K
Accrued payroll and
employee related...
$2,277K
Depreciation and
amortization
$615K
Retirement and impairment
of property and...
$409K
Amortization of debt discount
$194K
Amortization of debt issuance
costs
$2K
Net cash provided by
financing activities
$13,363K
Net cash provided by
investing activities
$11,858K
Net cash used in
operating activities
$1,331K
Canceled cashflow
$156,374K
Canceled cashflow
$6,127K
Canceled cashflow
$24,104K
Net increase
(decrease) in cash and cash...
$26,552K
Cash paid for
extinguishment-Two Thousand Twenty...
$125,000K
Cash paid for
extinguishment-Notes Payable
$25,000K
Cash paid for notes
payable debt issuance...
$3,406K
Cash paid for
issuance costs of stock
$1,531K
Cash paid for notes
payable debt issuance...
$1,386K
Receipts for stock issued
under the equity...
-$51K
Purchases of short-term
investments
$6,127K
Net loss
-$17,241K
Prepaid expenses and
other assets
$5,248K
Accounts receivable
$1,116K
something is missing
-$349K
Accretion of discount on
short-term investments
$130K
Accounts payable
-$20K
Back
Back
Cash Flow
source: myfinsight.com
HERON THERAPEUTICS, INC. DE (HRTX)
HERON THERAPEUTICS, INC. DE (HRTX)